Literature DB >> 24862308

The spleen and sickle cell disease: the sick(led) spleen.

Valentine Brousse1, Pierre Buffet, David Rees.   

Abstract

The spleen has a combined function of immune defence and quality control of senescent or altered red cells. It is the first organ injured in sickle cell anaemia (SCA) with evidence of hyposplenism present before 12 months in the majority of children. Repeated splenic vaso-occlusion leads to fibrosis and progressive atrophy of the organ (autosplenectomy), which is generally complete by 5 years in SCA. The precise sequence of pathogenic events leading to hyposplenism is unknown. Splenic injury is generally silent and progressive. It can be clinically overt with acute splenic sequestration of red cells, an unpredictable and life-threatening complication in infants. Splenomegaly, with or without hypersplenism, can also occur and can coexist with loss of function. Hyposplenism increases the susceptibility of SCA children to infection with encapsulated bacteria, which is notably reduced by penicillin prophylaxis and immunization. Whether hyposplenism indirectly increases the risk of vaso-occlusion or other circulatory complications remains to be determined.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  acute splenic sequestration; childhood; hyposplenism; sickle cell disease; spleen

Mesh:

Year:  2014        PMID: 24862308     DOI: 10.1111/bjh.12950

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  54 in total

Review 1.  Environmental determinants of severity in sickle cell disease.

Authors:  Sanjay Tewari; Valentine Brousse; Frédéric B Piel; Stephan Menzel; David C Rees
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

2.  Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin.

Authors:  Sarah L Reeves; Hannah K Jary; Jennifer P Gondhi; Mary Kleyn; Kevin J Dombkowski
Journal:  Blood Adv       Date:  2019-05-28

3.  COVID-19 and Vulnerable Populations in Sub-Saharan Africa.

Authors:  J A George; M R Maphayi; T Pillay
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Increased vancomycin dosing requirements in sickle cell disease due to hyperfiltration-dependent and independent pathways.

Authors:  Jin Han; Xu Zhang; Jennifer Oderinde; Santosh L Saraf; Michel Gowhari; Joharah Hassan; Shivi Jain; Victor R Gordeuk; Robert E Molokie
Journal:  Haematologica       Date:  2017-05-04       Impact factor: 9.941

5.  A novel non-invasive method to measure splenic filtration function in humans.

Authors:  Sara El Hoss; Michaël Dussiot; Olivier Renaud; Valentine Brousse; Wassim El Nemer
Journal:  Haematologica       Date:  2018-06-07       Impact factor: 9.941

6.  High-throughput microsphiltration to assess red blood cell deformability and screen for malaria transmission-blocking drugs.

Authors:  Julien Duez; Mario Carucci; Irene Garcia-Barbazan; Matias Corral; Oscar Perez; Jesus Luis Presa; Benoit Henry; Camille Roussel; Papa Alioune Ndour; Noemi Bahamontes Rosa; Laura Sanz; Francisco-Javier Gamo; Pierre Buffet
Journal:  Nat Protoc       Date:  2018-05-24       Impact factor: 13.491

7.  A locus on chromosome 5 shows African ancestry-limited association with alloimmunization in sickle cell disease.

Authors:  Lesedi M Williams; Zhihua Qi; Ken Batai; Stanley Hooker; Nancy J Hall; Roberto F Machado; Alice Chen; Sally Campbell-Lee; Yongtao Guan; Rick Kittles; Neil A Hanchard
Journal:  Blood Adv       Date:  2018-12-26

8.  Prevalence of Bartonella spp. Infection in Patients with Sickle Cell Disease.

Authors:  Tânia Cristina Benetti Soares; Gustavo Alves Brito Isaias; Amanda Roberta de Almeida; Marina Rovani Drummond; Marilene Neves da Silva; Bruno Grosselli Lania; Gislaine Vieira-Damiani; Sara Teresinha Olalla Saad; Marna Elise Ericson; Kalpna Gupta; Paulo Eduardo Neves Ferreira Velho
Journal:  Vector Borne Zoonotic Dis       Date:  2020-02-03       Impact factor: 2.133

9.  Laparoscopic Splenectomy Alone for Sickle Cell Disease: Account of 50 paediatric cases.

Authors:  Zainab N Al-Balushi; Khalid M Bhatti; Muhammad T Ehsan; Yousuf Al-Shaqsi; Nawal A R Al-Sharji; Hatem A A Mady; Mahmoud H Sherif
Journal:  Sultan Qaboos Univ Med J       Date:  2016-11-30

10.  Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review.

Authors:  Sri Riyati Sugiarto; Brioni R Moore; Julie Makani; Timothy M E Davis
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.